Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America.
Bernabe-Ramirez C, Velazquez AI, Olazagasti C, Decat Bergerot C, Bergerot PG, Corona Cruz J, Riano I, Adaniel C, Ramirez F, Anampa J, Cajina C, Mena E, Gracia E, Menendez A, Idrovo H, Bezares R, Castillo Fernandez OO, Duque L, Corrales-Rodríguez L, Ramos G, Kihn-Alarcón AJ, Schlam I, Bruno X, Umanzor G, Castro JL, Losco F, Ubillos L, Richardet E, Soto-Perez-de-Celis E, Duma N; HOLA COVID-19 Study Group. Bernabe-Ramirez C, et al. Among authors: schlam i. JCO Glob Oncol. 2022 Mar;8:e2100251. doi: 10.1200/GO.21.00251. JCO Glob Oncol. 2022. PMID: 35245084 Free PMC article.
Managing adverse events of sacituzumab govitecan.
Schlam I, Tarantino P, Tolaney SM. Schlam I, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1103-1111. doi: 10.1080/14712598.2023.2267975. Epub 2023 Dec 15. Expert Opin Biol Ther. 2023. PMID: 37800595 Review.
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study.
Shah P, Glueck CJ, Goldenberg N, Min S, Mahida C, Schlam I, Rothschild M, Huda A, Wang P. Shah P, et al. Among authors: schlam i. Lipids Health Dis. 2017 Jan 23;16(1):19. doi: 10.1186/s12944-017-0416-7. Lipids Health Dis. 2017. PMID: 28115017 Free PMC article.
Emerging Targeted Therapies for Early Breast Cancer.
Schlam I, Tarantino P, Morganti S, Lynce F, Trapani D, Mayer EL, Garrido-Castro AC, Waks A, Tolaney SM. Schlam I, et al. Drugs. 2022 Sep;82(14):1437-1451. doi: 10.1007/s40265-022-01781-5. Epub 2022 Oct 7. Drugs. 2022. PMID: 36207645 Review.
41 results